Ceretas Limited (ASX: CTS)
Health Care · Health Care Equipment & Supplies · AU
AU$0.88
-1.69% today · +50.9% 1Y
Ceretas Limited (ASX: CTS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $43.58M.
Over the last twelve months the share price has gained 50.9%, trading between 0.43 and 1.11.
Tweenvest scores Ceretas Limited across four factors: quality 45/100, value 69/100. Its strongest factor is value.
CTS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.58M
- Revenue (TTM)
- $857.55K
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- AU$1.11
- 52-week low
- AU$0.43
- Avg volume (3M)
- —
- Shares outstanding
- 71.38M
- Employees
- —
- Next earnings
- —
About Ceretas Limited
Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.
- ISIN
- AU0000475766
- Founded
- 2024
- Listed since
- Jul 23, 2026
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BrainCool AB (publ)OM: BRAIN | $44.78M | Skr1.13 | +3.47% |
| Epiminder LimitedASX: EPI | $44.60M | AU$0.30 | +13.46% |
| Suzhou Basecare Medical Corporation LimitedSEHK: 2170 | $43.92M | HK$1.26 | -0.40% |
| Broncus Holding CorporationSEHK: 2216 | $43.66M | HK$0.65 | -12.75% |
| DRGEM CorporationKOSDAQ: A263690 | $42.95M | ₩5,300.00 | +2.32% |
| SomnoMed LimitedASX: SOM | $42.17M | AU$0.28 | -5.17% |
| CVRx, Inc.NasdaqGS: CVRX | $42.09M | $1.58 | -5.95% |
| JMI Hospital Requisite Manufacturing LimitedDSE: JHRML | $42.02M | Tk41.30 | -3.73% |
Figures last refreshed Oct 11, 2026.